See All Slides - tctmd.com

Slides

Presentation

SALUS I Trial Update

Presenter: E. Murat Tuzcu

October 29, 2013

Presentation TCT 2013

TCT-71. The Association Between Tissue Characteristics assessed with Optical Coherence Tomography and Midterm Results After Percutaneous Coronary Intervention for In-stent...

Presenter: Takeshi Tada

October 29, 2013

Presentation TCT 2013

Silent Atrial Fibrillation: An Under-Appreciated Threat

Presenter: Taya Glotzer

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

How Would I Treat This Case?

Presenter: Thierry Lefevre

October 29, 2013

Presentation

Coronary Calcification: Insights from Angiography, IVUS, and OCT

Presenter: Gary Mintz

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

Presenter: Fumiyuki Otsuka

October 29, 2013

Presentation TCT 2013

How Would I Treat This Case?(2)

Presenter: Alejandro Cherro

October 29, 2013

Presentation TCT 2013

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Presenter: Sundeep Adusumalli

October 29, 2013

Advertisement

Slides

SALUS I Trial Update

TCT-71. The Association Between Tissue Characteristics assessed with Optical Coherence Tomography and Midterm Results After Percutaneous Coronary Intervention for In-stent...

Silent Atrial Fibrillation: An Under-Appreciated Threat

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

How Would I Treat This Case?

Coronary Calcification: Insights from Angiography, IVUS, and OCT

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Long-term Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold versus Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model

How Would I Treat This Case?(2)

TCT-55. Outcomes of Transfemoral Bivalirudin are Equivalent to Transradial PCI. “Old Dogs Don't Need to Learn New Tricks”

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content